Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players’ financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

Structural Heart Devices Companies

Several companies were actively involved in the development and manufacturing of structural heart devices. These devices are designed to treat and manage various conditions related to the heart's structure, such as congenital heart defects, valvular diseases, and other structural abnormalities. Keep in mind that the landscape may have changed, and new companies may have emerged since my last update.

Structural Heart Devices Key CompaniesLatest Structural Heart Devices Companies Update

October 2023: Abbott disclosed information regarding the efficacy of its minimally invasive cardiac devices in the treatment of mitral and tricuspid valve disease, derived from late-breaking presentations. The data encompass results obtained from the pivotal trial TRILUMINATE™, which provide further support for the safety and efficacy of the TriClip™ transcatheter edge-to-edge repair (TEER) system in cases where patients have developed severe symptomatic tricuspid regurgitation (TR) despite receiving optimal medical treatment. Additionally, the organization disclosed novel findings from the MitraClip™ EXPAND G4 real-world registry that underscore the advantages of the apparatus among a wide spectrum of patients afflicted with mitral regurgitation. In patients with MR and TR, leaking valves can lessen the volume of blood circulated through the body and cause the heart to work harder than it should. Subsequently, MR and TR can precipitate additional cardiovascular complications and significantly impair an individual's overall well-being.


October 2023: FEops, a prominent entity in personalized predictive planning for structural heart interventions, declared its collaboration with TeraRecon from ConcertAI to facilitate the commercialization of the Left Atrial Appendage (LAA) occlusion workflow of FEops HEARTguide. The collaboration will primarily target the United States market. Utilizing digital twin technology, FEops HEARTguide™ is an unprecedented cloud-based procedure planning solution in the structural heart industry. With the introduction of the LAA occlusion workflow in the United States, FEops HEARTguide™ empowers physicians in the United States to virtually simulate clinical scenarios involving FDA-approved LAA devices in various implant positions and sizes. This tool assists physicians in determining the most suitable size and position for each patient prior to performing the intervention.List of Structural Heart Devices Key companies in the market

  • Edwards Lifesciences Corporation (US)

  • Medtronic plc (Ireland)

  • Abbott (US)

  • Boston Scientific Corporation (US)

  • LivaNova plc (UK)

  • Jude Medical

  • Biometrics

  • Come BV

  • JenaValve Technology Inc.

  • CardioKinetix

  • Cook Group Incorporated (US)

Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Kindly complete the form below to receive a free sample of this Report
Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.